IGF2BP2 and cholangiocarcinoma: Clinically, we have also shown that m6A writers, IGF2BP2 and CTNNB1, were highly expressed in CCA patient samples, suggesting their potential roles for the detection of CCA, especially when these molecular were simultaneously evaluated.